.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Persy’s mix tilted toward Capsules at 47.9% share with 20.4% year-over-year growth and 36.4% month-over-month growth, while Concentrates held 44.3% share with 505.9% year-over-year and 27.0% month-over-month gains. Vapor Pens remained a small but accelerating slice at 4.5% share, surging 536.5% year-over-year and 123.0% month-over-month, whereas Pre-Roll slipped to 3.3% share with 94.2% year-over-year growth but an 8.7% month-over-month decline. With Capsules ranked 16th in Ontario and the average price up 27.1% year-over-year to $36.16, the pattern implies a portfolio leaning on two mid-to-high-priced pillars (Capsules and Concentrates) while nurturing a fast-ramping, low-base Vapor Pens line and pruning momentum in Pre-Roll.
The simultaneous 505.9% year-over-year surge in Concentrates and 536.5% in Vapor Pens, alongside a 36.4% month-over-month lift in Capsules and a 27.0% month-over-month lift in Concentrates, implies Persy is capturing higher-intensity use occasions and tolerating price elasticity in premium formats. The 8.7% month-over-month contraction in Pre-Roll paired with a 4.5% share for Vapor Pens suggests substitution toward inhalable formats with higher average prices, while maintaining a defensible Capsules base at a 16th rank in Ontario; net effect, Persy’s positioning trends toward premium function-first formats where rapid mix shifts can compound share even as lower-priced Pre-Roll is deprioritized.
Competitive Landscape
Persy sits at #16 in ON Capsules in October 2026, unchanged from #16 in October 2025, marking a 0-rank YoY move and leaving its 3-month position steady at #16; this static placement contrasts with Glacial Gold rising from #4 to #2 YoY alongside a 75.48% sales increase, while Redecan slipped from #2 to #5 with a -13.59% sales decline. Against the category leader, Aspire held #1 YoY with 21.82% sales growth, and Tweed fell from #3 to #4 with -10.98% sales, indicating upward mobility is occurring above Persy even as Persy’s best-ever rank remains #16 in October 2026; the flat rank trajectory implies Persy is neither capturing share from weakening incumbents nor benefiting from growth pockets, and without a step-change in velocity or distribution it is likely to remain range-bound in the mid-teens.
Notable Products
Persy’s October 2026 sales are highly concentrated in two formats: Capsules account for 47.9% and Concentrates add 44.3%, with Strain Specific Full Spectrum Live Rosin Capsules 30-Pack (300mg) alone at 47.9%. That concentration means most of Persy’s revenue comes from Capsules and Rosin, so most of its sales ride on these two formats.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
